Developer docs
API playgroundTry for free, no card

Search company profiles

ClariMed

Full company profile

uuid003wicb

Namestring
ClariMed
Legal namestring
ClariMed, Inc.
Websiteurl
clarimed.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

ClariMed is a human-centered medical device development and regulatory services firm headquartered in Chadds Ford, Pennsylvania, that provides an integrated end-to-end platform spanning human factors engineering, usability testing, quality management system (QMS) services, regulatory strategy, digital/UX design, AI/ML integration, cybersecurity, and market research. Founded in January 2023 as a platform investment by healthcare-focused private equity firm NaviMed Capital ($400M+ AUM), the company was built by simultaneously acquiring two established human factors boutiques — UserWise (San Jose, January 2023) and Harvey Medical (Cambridge UK, February 2023) — and has since added We Are Human (Atlanta, August 2025). Under CEO Kelley Kendle, the company has scaled from approximately 20 to 70+ consultants across five global offices (Chadds Ford PA, Cambridge MA, San Jose CA, Atlanta GA, Cambridge UK and Leeds UK), achieving ISO 13485:2016 certification in July 2025 and Inc. 5000 recognition in September 2025.

The company's core technology is a five-phase iterative usability engineering methodology — user research, risk analysis, iterative prototyping/testing, usability validation, and HF submission support for FDA and CE marking — combined with specialized simulated-use environments (10,000 sq ft facilities in San Jose and Cambridge UK featuring surgical suites, observation areas and a functioning ambulance simulator) that allow realistic formative and validation testing across home, clinical and surgical contexts. Service delivery is offered through four commercial models: project-based consulting, embedded resources, monthly retainers, and end-to-end multi-year partnerships, allowing sponsors to scope engagements from a single HF validation study to a full product lifecycle program.

ClariMed targets pharmaceutical and medical device manufacturers, with a secondary segment in digital health and SaMD companies; named engagements include Béa Fertility (UK at-home ICI kit), a large international pharmaceutical company (migraine inhaler, biosimilar prefilled syringes for AMD/DME), a rechargeable implanted system developer, and a kidney transplant device developer. Marketing relies on thought leadership content, industry conference presence (MD&M West, MEDevice Silicon Valley, Pharmapack Europe, EU Medical Device Human Factors Conference), webinars, and direct B2B enterprise sales across the US, UK and EU markets.

Short descriptiontext

ClariMed is a US-headquartered, PE-backed (NaviMed Capital) MedTech services firm that delivers integrated human factors engineering, usability testing, regulatory strategy, quality systems, and digital solutions to pharmaceutical and medical device manufacturers across the US, UK and EU, operating from five global offices with 70+ consultants.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersChadds Ford, United States
HQ citystring
Chadds Ford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device development, human factors engineering, usability testing services, regulatory affairs consulting, quality management systems
Industry2 codes
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Professional, Scientific, and Technical Services541
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Health Services8000
  • Services-Computer Programming Services7371
Product category
Medical Device Regulatory & Development Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Professional Services - Human Factors & Usability Studies
TypeProfessional Services
Description

Consulting services for human factors engineering, usability testing, and market research to support medical device development and regulatory submissions.

clarimed.com
2Strategy & Advisory Services
TypeProfessional Services
Description

Regulatory strategy, gap analysis, agency representation, and compliance advisory services for global markets (US, EU, China, Japan).

clarimed.com
3Quality Services
TypeProfessional Services
Description

Quality management system implementation, document control, design control, audits, and risk management services aligned with ISO 13485, ISO 14971, and regulatory requirements.

clarimed.com
4Digital Solutions
TypeProfessional Services
Description

UI/UX design, software development, AI/ML integration, cybersecurity solutions, and cloud connectivity services for medical devices and digital health products.

clarimed.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details4 tiers
1Project-Based Consulting
ModelOtherBilling cadencePay-as-you-go
Notes

Flexible engagement model for targeted project assistance with defined scope and deliverables.

clarimed.com
2Embedded Resources
ModelOtherBilling cadenceMonthly
Notes

Ongoing resource deployment model for continuous support and expertise integration.

clarimed.com
3Retainer Model
ModelSubscriptionBilling cadenceMonthly
Notes

Committed engagement with dedicated resources and priority access to expertise.

clarimed.com
4End-to-end Services
ModelOtherBilling cadenceMulti-year contract
Notes

Comprehensive full-service partnership covering entire product development lifecycle.

clarimed.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ClariMed provides integrated, end-to-end human-centered medical device, combination product, and IVD development services. The firm delivers human factors and usability engineering studies, quality management system implementation, regulatory strategy and advisory, digital/UI-UX design, cybersecurity, AI/ML integration, and qualitative market research to pharmaceutical and medical device manufacturers across US, UK, and EU markets. Services are offered through project-based, embedded resource, retainer, and full-lifecycle engagement models.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Reduced document approval and release timeline by 40% for auto-injector manufacturer client
+2 more records
Product overview1 text field

ClariMed is a human-centered medical device development and regulatory services company offering an integrated, end-to-end service platform. The core offerings include Human Factors & Usability Studies, Quality Services (QMS), Digital Solutions, Strategy & Advisory, and Market Insights, delivered through flexible engagement models (Project-Based Consulting, Embedded Resources, Retainer Model, and End-to-End). The company has grown through acquisitions of UserWise (human factors/usability engineering), Harvey Medical (UK/EU human factors and market research), and We Are Human (Southeast US usability), all now fully integrated into ClariMed's unified practice.

Product and service5 records
1Human Factors & Usability Studies
CategoryHuman Factors Engineering
2Quality Services (QMS)
CategoryQuality Management Systems
3Digital Solutions
CategoryDigital Health & Software
4Strategy & Advisory
CategoryRegulatory Consulting
5Market Insights
CategoryMarket Research
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierKeyTypeStrategic or Co-development PartnerAnnounced on2025-08-12
Description

Acquired Atlanta-based usability lab and expert team led by Principal Annmarie Nicolson, expanding ClariMed's presence in the Southeast US market.

2Harvey Medical
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-02-06
Description

Acquired UK-based Harvey Medical, a medical human factors and market research provider with offices in Cambridge, UK and Utrecht, NL. Founder Louisa Harvey serves as Principal. The acquisition expanded ClariMed's European footprint and regional expertise.

clarimed.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-30
Description

Acquired San Jose-based UserWise, the leading independent human factors provider offering human factors and usability engineering services, usability study recruitment, market research facilities, and IRB services. Founder Shannon Clark continues to lead the organization.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Regulatory and scientific services firm (parent of Synchrogenix) employing ClariMed CEO Kelley Kendle previously. Overlaps on regulatory strategy, medical writing, and combination product support, though Certara is more pharma/clinical-focused.

TypeDirect peer
Description

Medical device design, development, and manufacturing services firm providing human factors engineering, regulatory, and quality services. Closely comparable integrated MedTech services platform; Ximedica adds contract manufacturing capability.

3NAMSA
TypeDirect peer
Description

Medical device-focused CRO providing regulatory, quality, and testing services including human factors and usability engineering. Comparable to ClariMed in target customer (MedTech manufacturers) and integrated service platform model.

TypeBroad incumbent
Description

Global CRO and life sciences services giant with MedTech and human factors practices. Competes with ClariMed on large enterprise engagements where bundled CRO offerings can undercut specialist pricing, though lacks ClariMed's pure-play human factors depth.

TypeDirect peer
Description

Product development consultancy with medical device practice including human factors engineering and regulatory support from Cambridge UK. Comparable scale and service model, including premium-priced innovation work for medtech/pharma.

TypeBroad incumbent
Description

Mid-sized clinical CRO with growing medical device and combination product practice. Larger scale and broader clinical scope than ClariMed, but overlapping regulatory/human factors service lines for medical product sponsors.

TypeDirect peer
Description

Medical device product development and manufacturing services firm with human factors and design control capabilities. Comparable end-to-end services model targeting combination products and regulated devices.

TypeDirect peer
Description

Boutique human factors and usability engineering consultancy serving medical device and pharmaceutical clients. Most direct pure-play HF peer to ClariMed, particularly in user research and validation testing services.

TypeDirect peer
Description

Product development and technology consulting firm with medical device and life sciences practice offering human factors, regulatory, and software/digital services. Comparable integrated offering and similar customer base of mid-to-large MedTech clients.

TypeDirect peer
Description

UL's human factors and regulatory consulting practice for medical device and IVD manufacturers; competes directly with ClariMed on usability engineering, regulatory strategy, and global market access (US FDA, EU MDR, etc.). Closest direct peer in service scope.

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ClariMed

Medical Device Regulatory & Development Servicesclarimed.com

ClariMed is a US-headquartered, PE-backed (NaviMed Capital) MedTech services firm that delivers integrated human factors engineering, usability testing, regulatory strategy, quality systems, and digital solutions to pharmaceutical and medical device manufacturers across the US, UK and EU, operating from five global offices with 70+ consultants.

What ClariMed does

ClariMed is a human-centered medical device development and regulatory services firm headquartered in Chadds Ford, Pennsylvania, that provides an integrated end-to-end platform spanning human factors engineering, usability testing, quality management system (QMS) services, regulatory strategy, digital/UX design, AI/ML integration, cybersecurity, and market research. Founded in January 2023 as a platform investment by healthcare-focused private equity firm NaviMed Capital ($400M+ AUM), the company was built by simultaneously acquiring two established human factors boutiques — UserWise (San Jose, January 2023) and Harvey Medical (Cambridge UK, February 2023) — and has since added We Are Human (Atlanta, August 2025). Under CEO Kelley Kendle, the company has scaled from approximately 20 to 70+ consultants across five global offices (Chadds Ford PA, Cambridge MA, San Jose CA, Atlanta GA, Cambridge UK and Leeds UK), achieving ISO 13485:2016 certification in July 2025 and Inc. 5000 recognition in September 2025.

The company's core technology is a five-phase iterative usability engineering methodology — user research, risk analysis, iterative prototyping/testing, usability validation, and HF submission support for FDA and CE marking — combined with specialized simulated-use environments (10,000 sq ft facilities in San Jose and Cambridge UK featuring surgical suites, observation areas and a functioning ambulance simulator) that allow realistic formative and validation testing across home, clinical and surgical contexts. Service delivery is offered through four commercial models: project-based consulting, embedded resources, monthly retainers, and end-to-end multi-year partnerships, allowing sponsors to scope engagements from a single HF validation study to a full product lifecycle program.

ClariMed targets pharmaceutical and medical device manufacturers, with a secondary segment in digital health and SaMD companies; named engagements include Béa Fertility (UK at-home ICI kit), a large international pharmaceutical company (migraine inhaler, biosimilar prefilled syringes for AMD/DME), a rechargeable implanted system developer, and a kidney transplant device developer. Marketing relies on thought leadership content, industry conference presence (MD&M West, MEDevice Silicon Valley, Pharmapack Europe, EU Medical Device Human Factors Conference), webinars, and direct B2B enterprise sales across the US, UK and EU markets.

ClariMed firmographics

Firmographics
Name
ClariMed
Legal name
ClariMed, Inc.
Website
https://clarimed.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
51–100 employees
Short description
ClariMed is a US-headquartered, PE-backed (NaviMed Capital) MedTech services firm that delivers integrated human factors engineering, usability testing, regulatory strategy, quality systems, and digital solutions to pharmaceutical and medical device manufacturers across the US, UK and EU, operating from five global offices with 70+ consultants.
Ownership category
akta.pro rank

ClariMed industry classification

Industry
Product category
Medical Device Regulatory & Development Services
NAICS
Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (541), Computer Systems Design and Related Services (54151)
SIC
Services-Health Services (8000), Services-Computer Programming Services (7371)
akta.pro industry
PRIMARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Medical device development
  • Human factors engineering
  • Usability testing services
  • Regulatory affairs consulting
  • Quality management systems

Where ClariMed is headquartered

Location

Headquarters

HQ city
Chadds Ford
HQ country
United States
HQ region
North America

Offices6 records

Markets served

ClariMed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Professional Services - Human Factors & Usability Studies: Consulting services for human factors engineering, usability testing, and market research to support medical device development and regulatory submissions.
  2. Strategy & Advisory Services: Regulatory strategy, gap analysis, agency representation, and compliance advisory services for global markets (US, EU, China, Japan).
  3. Quality Services: Quality management system implementation, document control, design control, audits, and risk management services aligned with ISO 13485, ISO 14971, and regulatory requirements.
  4. Digital Solutions: UI/UX design, software development, AI/ML integration, cybersecurity solutions, and cloud connectivity services for medical devices and digital health products.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goProject-Based Consulting
OtherMonthlyEmbedded Resources
SubscriptionMonthlyRetainer Model
OtherMulti-year contractEnd-to-end Services

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

ClariMed product offering

Product offering

Core offering

ClariMed provides integrated, end-to-end human-centered medical device, combination product, and IVD development services. The firm delivers human factors and usability engineering studies, quality management system implementation, regulatory strategy and advisory, digital/UI-UX design, cybersecurity, AI/ML integration, and qualitative market research to pharmaceutical and medical device manufacturers across US, UK, and EU markets. Services are offered through project-based, embedded resource, retainer, and full-lifecycle engagement models.

Product overview

ClariMed is a human-centered medical device development and regulatory services company offering an integrated, end-to-end service platform. The core offerings include Human Factors & Usability Studies, Quality Services (QMS), Digital Solutions, Strategy & Advisory, and Market Insights, delivered through flexible engagement models (Project-Based Consulting, Embedded Resources, Retainer Model, and End-to-End). The company has grown through acquisitions of UserWise (human factors/usability engineering), Harvey Medical (UK/EU human factors and market research), and We Are Human (Southeast US usability), all now fully integrated into ClariMed's unified practice.

Differentiator

Problem solved

Functional benefit

Products and services

  • Human Factors & Usability Studies
  • Quality Services (QMS)
  • Digital Solutions
  • Strategy & Advisory
  • Market Insights

Quantifiable outcome

  • Reduced document approval and release timeline by 40% for auto-injector manufacturer client
  • +2 more outcomes

Companies that use ClariMed

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

ClariMed technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

ClariMed partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered key and core.

  • We Are HumankeyStrategic or Co-development Partner · 12 August 2025Acquired Atlanta-based usability lab and expert team led by Principal Annmarie Nicolson, expanding ClariMed's presence in the Southeast US market.
  • Harvey MedicalcoreStrategic or Co-development Partner · 6 February 2023Acquired UK-based Harvey Medical, a medical human factors and market research provider with offices in Cambridge, UK and Utrecht, NL. Founder Louisa Harvey serves as Principal. The acquisition expanded ClariMed's European footprint and regional expertise.
  • UserWise, LLCcoreStrategic or Co-development Partner · 30 January 2023Acquired San Jose-based UserWise, the leading independent human factors provider offering human factors and usability engineering services, usability study recruitment, market research facilities, and IRB services. Founder Shannon Clark continues to lead the organization.

Scale indicators6 records

Recent moves11 records

Expansion highlights6 records

ClariMed competitors and assessment

Company assessment

Broad incumbents

  • Certara: Regulatory and scientific services firm (parent of Synchrogenix) employing ClariMed CEO Kelley Kendle previously. Overlaps on regulatory strategy, medical writing, and combination product support, though Certara is more pharma/clinical-focused.
  • IQVIA: Global CRO and life sciences services giant with MedTech and human factors practices. Competes with ClariMed on large enterprise engagements where bundled CRO offerings can undercut specialist pricing, though lacks ClariMed's pure-play human factors depth.
  • Medpace: Mid-sized clinical CRO with growing medical device and combination product practice. Larger scale and broader clinical scope than ClariMed, but overlapping regulatory/human factors service lines for medical product sponsors.

Direct peers

  • Ximedica: Medical device design, development, and manufacturing services firm providing human factors engineering, regulatory, and quality services. Closely comparable integrated MedTech services platform; Ximedica adds contract manufacturing capability.
  • NAMSA: Medical device-focused CRO providing regulatory, quality, and testing services including human factors and usability engineering. Comparable to ClariMed in target customer (MedTech manufacturers) and integrated service platform model.
  • Cambridge Consultants: Product development consultancy with medical device practice including human factors engineering and regulatory support from Cambridge UK. Comparable scale and service model, including premium-priced innovation work for medtech/pharma.
  • Invetech: Medical device product development and manufacturing services firm with human factors and design control capabilities. Comparable end-to-end services model targeting combination products and regulated devices.
  • Design Science Consulting: Boutique human factors and usability engineering consultancy serving medical device and pharmaceutical clients. Most direct pure-play HF peer to ClariMed, particularly in user research and validation testing services.
  • Sagentia: Product development and technology consulting firm with medical device and life sciences practice offering human factors, regulatory, and software/digital services. Comparable integrated offering and similar customer base of mid-to-large MedTech clients.
  • Emergo by UL: UL's human factors and regulatory consulting practice for medical device and IVD manufacturers; competes directly with ClariMed on usability engineering, regulatory strategy, and global market access (US FDA, EU MDR, etc.). Closest direct peer in service scope.

Market position

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

ClariMed social profiles

Digital presence

ClariMed compliance and trust

Trust signal

Compliance4 records

ClariMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ClariMed leadership team

Management profile

Number of profiles

Profiles10 records

ClariMed subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

ClariMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ClariMed M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ClariMed

What does ClariMed do?

ClariMed provides integrated, end-to-end human-centered medical device, combination product, and IVD development services. The firm delivers human factors and usability engineering studies, quality management system implementation, regulatory strategy and advisory, digital/UI-UX design, cybersecurity, AI/ML integration, and qualitative market research to pharmaceutical and medical device manufacturers across US, UK, and EU markets. Services are offered through project-based, embedded resource, retainer, and full-lifecycle engagement models.

Is ClariMed a public or private company?

ClariMed is a private company. It is classified as private equity controlled and is currently operating.

When was ClariMed founded?

ClariMed was founded in 2023. It employs 51 to 100 people.

Where is ClariMed based?

ClariMed is headquartered in Chadds Ford, United States, in the North America region.

How does ClariMed make money?

Four revenue lines are on record. Professional Services - Human Factors & Usability Studies are the primary driver. The others are strategy & Advisory Services, quality Services and digital Solutions.

Who are ClariMed's main competitors?

Broad incumbents on record are Certara, IQVIA and Medpace. Direct peers are Ximedica, NAMSA, Cambridge Consultants, Invetech, Design Science Consulting, Sagentia and Emergo by UL.

Does ClariMed have an API?

No public API is recorded for ClariMed.

What industry is ClariMed in?

ClariMed's product category is Medical Device Regulatory & Development Services. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease), with a secondary code of HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement. Its NAICS code is 5417 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical Device and Diagnostic industryHow Gender Bias in Medical Devices Puts Women at RiskAt MD&M West in Anaheim, California, ClariMed experts Denise Forkey and Aarti Swaminathan presented research showing that women remain significantly under-represented in medical device trials, comprising only one-third of participants across 195 trials and just 29% in high-risk implant studies. A 2019 study revealed that of 340,000 device deaths and injuries, 67% of those harmed were women, with female-specific implantable devices showing higher rates of life-threatening outcomes compared to male-specific implants. The global femtech market, currently valued at $60 billion, is expected to grow 10% over the next decade as the FDA increases focus on requiring manufacturers to balance demographics and stratify data by sex in device trials.Design News Serving the 21st Century Design EngineerGender Bias in Medical Device Research Harms WomenAarti Swaminathan, senior human factors consultant at ClariMed Inc., presented at MEDevice Silicon Valley on the underrepresentation of women in medical device research, revealing that only about one-third of trial participants across 195 medical device trials were women, dropping to 29% for high-risk implants such as stents and pacemakers. She cited FDA MAUDE database research showing higher rates of life-threatening outcomes, disability, and death for female-specific implants compared to male-specific ones. She outlined three categories of bias—physical, computational, and interpretational—and recommended evidence-based usability practices, diverse user testing, and sex-stratified data analysis during product development to improve health outcomes.Clarimed5 Document Control Best Practices for Product DevelopmentClariMed, a provider of quality services for product development, outlines five best practices to streamline document control processes and reduce compliance risks. The recommended strategies include implementing centralized systems, establishing clear hierarchies, automating approval workflows, integrating with development tools, and conducting regular audits. These measures are designed to help companies minimize errors and accelerate time-to-market.ClarimedClariMed's Portfolio of SuccessThe article presents a portfolio of case studies from ClariMed, highlighting its services in human factors testing and usability research for medical device manufacturers. These engagements involved optimizing product designs and documentation to facilitate successful FDA submissions and improve patient outcomes. The text serves as a promotional overview of the company's capabilities rather than reporting on a specific market event.PR NewswireClariMed Inc. acquiert We Are Human et étend sa croissance au marché du Sud-EstClariMed Inc., a global leader in human-centered medical device development and regulatory services, has announced the strategic acquisition of We Are Human, a UK and US-based consulting firm specializing in user-centered design and research for innovative medical technology. The acquisition brings We Are Human's Atlanta-based research center into ClariMed's growing network, marking the company's first Southeast location, and adds founder Annmarie Nicolson to ClariMed's leadership team. The move aligns with ClariMed's growth strategy of building comprehensive, human-centered solutions for medical device manufacturers while expanding its geographic footprint across the US and UK.Pulse 2.0ClariMed Acquiring Consultancy We Are HumanClariMed acquired We Are Human, a UK-US consultancy, to expand into the Southeast US via an Atlanta facility. The deal brings ISO 13485 certification and expertise in usability engineering, with founder Annmarie Nicolson joining as Principal. ClariMed now operates in six locations, aiming to speed client development and time to market.PR NewswireClariMed Inc. übernimmt We Are Human und expandiert damit in den südöstlichen MarktClariMed, Inc. announced the strategic acquisition of We Are Human, a UK and US-based consulting firm specializing in user-centered design and research for MedTech innovations. The acquisition expands ClariMed's geographic reach into the southeastern US through We Are Human's research facility in Atlanta, Georgia, marking ClariMed's first location in that region. Founder Annmarie Nicolson will join ClariMed as Principal, bringing expertise in formative research, contextual inquiry, and UX research for MedTech innovation.PR NewswireClariMed Inc. adquiere We Are Human y expande su crecimiento al mercado del sudesteClariMed, Inc. announced the strategic acquisition of We Are Human, a UK and US-based consulting firm specializing in user-centered design and research for medical technology innovation. The acquisition integrates We Are Human's complete team and Atlanta research center into ClariMed's network, expanding ClariMed's geographic reach in the southeastern United States while strengthening its user-centered design and regulatory compliance capabilities. The integration establishes ClariMed's first southeastern headquarters, joining existing offices in Pennsylvania, Massachusetts, California, and the United Kingdom.PR NewswireClariMed Inc. Erlangt ISO 13485:2016-Zertifizierung und stärkt damit die globalen Entwicklungskapazitäten für medizinische GeräteClariMed, Inc. has obtained ISO 13485:2016 certification from BSI, a key quality management standard for medical device development, representing a significant milestone in the company's commitment to quality and global expansion.PR NewswireClariMed Inc. obtient la certification ISO 13485:2016, renforçant ainsi ses capacités de développement de dispositifs médicaux à l'échelle mondialeClariMed, Inc. has obtained ISO 13485:2016 certification from BSI, marking a significant milestone in the company's commitment to quality excellence and global expansion in medical device development services.